BVMF/S1NN34 (BVMF/S1NN34)

Brazil Stock Exchange: BVMF/S1NN34 · BRL

R$31.7

-0.57 (-1.8%)· Recorded snapshot

Market cap	67.9B
Revenue (ttm)	32.5B
Net income (ttm)	3.3B
EPS (ttm)	R$1.61
P/E (trailing)	19.7x
P/E (forward)	12.8x
Dividend	R$0.74 (2.35%)
Volume	1
Beta	0.67

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 32.5B
Net income (ttm): 3.3B
EPS (ttm): R$1.61
P/E (trailing): 19.7x
P/E (forward): 12.8x
Market cap: 67.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E12.8

P25 n/aP50 n/aP75 n/a

Trailing P/E19.7

P25 n/aP50 n/aP75 n/a

ROE11.9

P25 n/aP50 n/aP75 n/a

ROIC8.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/S1NN34 indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

USD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United Kingdom
Country code	BR
Earnings date	2026-11-05
Employees	17,000
Employees change	-361
Employees growth	-2.08%
Enterprise value	BRL 84.5B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-27
First seen	2026-05-10
Fiscal year end	December
Founded	1856
Industry	Medical Devices
Is primary listing	No
ISIN number	BRS1NNBDR009
Last earnings date	2026-08-04
Last refreshed	2026-10-30
Market cap	BRL 67.9B
Next earnings date	2026-11-05
Price	BRL 31.68
Price currency	BRL
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-28
Symbol	bvmf/S1NN34
Website	https://www.smith-nephew.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	30.8x
Average P/E ratio (3Y)	31.17x
Average P/E ratio (5Y)	34.14x
Earnings yield	5.08%
EV/Earnings	25.77x
EV/EBIT	15.2x
EV/EBITDA	9.96x
EV/FCF	19.14x
EV/Sales	2.45x
FCF / EV yield	5.23%
FCF yield	6.5%
Forward P/E	12.79x
Graham number	20.72773
Graham upside	-34.57%
Lynch fair value	BRL 7.65
Lynch upside	-75.85%
P/(FCF - SBC) ratio	16.46x
P/(OCF - SBC) ratio	10.25x
P/B ratio	2.54x
P/E ratio	19.69x
P/FCF ratio	15.38x
P/OCF ratio	9.82x
P/S ratio	2.09x
Price / tangible book value	15.75x
Price/EBITDA ratio	9.51x
Sector forward P/E	10.79x
Sector P/E	32.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	14.22%
EBITDA margin	21.94%
Effective tax rate	20.33%
FCF margin	13.03%
Gross margin	68.44%
Operating margin	14.22%
Pretax margin	12.65%
Profit margin	10.08%
Profit per employee	BRL 192,939
Profitable quarters	53
Profitable years	31
Revenue per employee	BRL 1.9M
ROA	5.16%
ROA (5Y)	4.67%
ROCE	10%
ROE	11.85%
ROE (5Y)	7.7%
ROIC	8.69%
ROIC (5Y)	8.64%
SBC / revenue	0.89%
Tax / revenue	2.57%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	31.78%
EPS growth (Q)	5.71%
EPS growth (QoQ)	-8.19%
EPS growth 10Y	6.37%
EPS growth 3Y	43.34%
EPS growth 5Y	3.16%
EPS growth quarters	6
EPS growth years	3
FCF growth	7.28%
FCF growth (Q)	1.17%
FCF growth (QoQ)	-56.3%
FCF growth 3Y	238.73%
FCF growth 5Y	1.47%
Gross profit growth	2.76%
Gross profit growth (Q)	5.02%
Gross profit growth 3Y	4.62%
Gross profit growth 5Y	3.77%
Net income growth	29.33%
Net income growth (Q)	3.41%
Net income growth (QoQ)	-8.73%
Net income growth 3Y	42.81%
Net income growth 5Y	2.8%
Net income growth quarters	6
Net income growth years	3
OCF growth	16.94%
OCF growth (Q)	13.64%
OCF growth (QoQ)	-49.38%
OCF growth 10Y	5.17%
OCF growth 3Y	52.98%
OCF growth 5Y	1.8%
Operating income growth	-9.22%
Operating income growth (Q)	4.43%
Operating income growth 3Y	9.31%
Operating income growth 5Y	5.77%
Revenue growth	5.99%
Revenue growth (Q)	4.59%
Revenue growth (QoQ)	-3.31%
Revenue growth 10Y	3%
Revenue growth 3Y	5.61%
Revenue growth 5Y	4.22%
Revenue growth quarters	11
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -2.5B
Depreciation and amortization	BRL 2.6B
EBIT	BRL 4.6B
EBITDA	BRL 7.1B
EPS	BRL 1.61
Financing cash flow	BRL -3B
Free cash flow	BRL 4.4B
Free cash flow minus SBC	BRL 4.1B
Gross profit	BRL 22.3B
Income taxes	BRL 836.8M
Investing cash flow	BRL -3.5B
Net borrowing	BRL 1.9B
Net cash flow	BRL 397.7M
Net income	BRL 3.3B
Operating cash flow minus SBC	BRL 6.6B
Operating income	BRL 4.6B
Revenue	BRL 32.5B
Stock-based compensation	BRL 289.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.26
Book value per share	BRL 31.44
Debt / EBITDA	2.65
Debt / equity	0.73
Debt / FCF	4.43
Goodwill	BRL 17.4B
Interest coverage	6.59
Long-term assets	BRL 33.3B
Long-term liabilities	BRL 19.1B
Net cash (debt)	BRL -15.7B
Net cash / market cap	-23.05%
Net debt / EBITDA	2.19
Net debt / equity	0.59
Net debt / FCF	3.55
Piotroski F-Score	6
Property, plant and equipment	BRL 8.7B
Shareholders' equity	BRL 26.8B
Tangible book value	BRL 4.3B
Tangible book value per share	BRL 5.07
Total assets	BRL 56.9B
Total cash	BRL 3.9B
Total debt	BRL 19.6B
Total liabilities	BRL 30.1B
WACC	6.81%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.58
Current assets	BRL 23.6B
Current liabilities	BRL 11B
Current ratio	2.14
Inventory turnover	0.87
Net working capital	BRL 11.1B
Quick ratio	1.11
Working capital	BRL 12.1B
Working capital turnover	12

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.79%
Dividend growth	3.27%
Dividend growth (3Y)	-0.17%
Dividend growth years	0
Dividend payment date	2026-11-12
Dividend payment years	5
Dividend payout frequency	Semi-Annual
Dividend per share	BRL 0.74
Dividend yield	2.35%
Ex-dividend date	2026-10-01
Last dividend	BRL 0.04
Payout ratio	52.44%
Shareholder yield	4.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	-1.77%
1M price change	6.24%
1M total return	7.43%
1W price change	-1.77%
1W total return	-1.77%
1Y price change	-17.18%
1Y return CAGR	-15.12%
1Y total return	-15.11%
20-day SMA	BRL 32.79
3M price change	0.19%
3M total return	1.31%
3Y price change	40.8%
3Y return CAGR	14.9%
3Y total return	51.72%
50-day SMA	BRL 33.69
52-week high	BRL 36.64
52-week high date	2026-01-09
52-week low	BRL 27.74
52-week low date	2026-09-29
6M price change	-6.3%
6M total return	-5.25%
All-time high	BRL 40.88
All-time high date	2025-08-21
All-time low	BRL 22.50
All-time low date	2023-10-20
Average true range (ATR)	BRL 1.03
Average volume	7.1
Beta (5Y)	0.67
Change from 52-week high	-13.54%
Change from 52-week low	14.2%
Change from all-time high	-22.5%
Change from all-time low	40.8%
Change from open	0%
Day's gap	-1.77%
Dollar volume	BRL 31.68
High price	BRL 31.68
Low price	BRL 31.68
Monthly RSI	50.64
Open price	BRL 31.68
Previous close	BRL 32.25
Price vs 20-day SMA	-3.38%
Price vs 50-day SMA	-5.95%
Relative volume	0.14
RSI	46.69
Sharpe ratio	1.42
Sortino ratio	2.47
Volume	1
Weekly RSI	57.16
YTD price change	-12.97%
YTD total return	-10.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	828.7M
Shares change (QoQ)	-0.61%
Shares change (YoY)	-1.79%
Shares held by insiders	0.13%
Shares held by institutions	90.1%

Deeper analysis on BVMF/S1NN34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/S1NN34 report

Is a complete BVMF/S1NN34 research report available?

No complete published report is available for bvmf/S1NN34 (BVMF/S1NN34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/S1NN34 (BVMF/S1NN34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/S1NN34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/S1NN34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/S1NN34

Frequently asked questions